欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6270/004
药品名称Enoxaparin Ledraxen 4.000 IE (40 mg)/0,4 ml Injektionslösung in einer Fertigspritze
活性成分
    • enoxaparin sodium 4000.0 anti-Xa IU/0.4
剂型Solution for injection in pre-filled syringe
上市许可持有人Venipharm 4 Bureaux de la Colline 92210 Saint-Cloud France
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Ireland (IE)
    • Slovakia (SK)
    • France (FR)
    • Austria (AT)
    • Croatia (HR)
    • Portugal (PT)
    • Slovenia (SI)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Enoxaparin sodium Ledraxen 4000 TV (40 mg)/0,4 ml injekcinis tirpalas užpildytame švirkšte
    • Estonia (EE)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Sweden (SE)
    • Cyprus (CY)
      Enoxaparin Ledraxen 4.000 IE (40 mg)/0,4 ml solution for injection in pre-filled syringe
    • Czechia (CZ)
      Enoxaparin Ledraxen
许可日期2019/02/11
最近更新日期2024/05/23
药物ATC编码
    • B01AB05 enoxaparin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase